alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1



CERTIFICATION OF CHIEF EXECUTIVE OFFICER

AND CHIEF FINANCIAL OFFICER

PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. 1350)



In connection with the Annual Report of Wells
Real Estate Fund II (the Registrant) on Form 10-K for the year ended December 31, 2003, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Leo F. Wells, III, Chief Executive
Officer of the corporate General partner of the Registrant, and Douglas P. Williams, Chief Financial Officer of the corporate General partner of the Registrant, hereby certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.
1350), that, to the best of our knowledge and belief:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |                                                           
| |  | ----------------------------------------------------------
|
| | 
| |  | /s/ Leo F. Wells, III                                     
| |  |                                                           
| |  | Leo F. Wells, III Chief Executive Officer
March 19, 2004  
|
| | 
| |  | /s/ Douglas P. Williams                                   
| |  |                                                           
| |  | Douglas P. Williams Chief Financial
Officer March 19, 2004
Electronically FiledIntermediate Court of AppealsCAAP-12-000102321-MAY-201303:22 PM
Exhibit 99.1

                  CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER
                           AND CHIEF FINANCIAL OFFICER
                          RELATING TO A PERIODIC REPORT
                         CONTAINING FINANCIAL STATEMENTS

      I, Raymond P. Warrell, Jr., M.D., Chief Executive Officer and Acting
Chief Financial Officer of Genta Incorporated, a Delaware corporation (the
"Company"), hereby certifies that:

      (1) The Company's periodic report on Form 10-Q for the period ended June
30, 2002 (the "Form 10-Q") fully complies with the requirements of Section 13(a)
of the Securities Exchange Act of 1934, as amended; and

      (2) The information contained in the Form 10-Q fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


/s/ Raymond P. Warrell, Jr., M.D.
---------------------------------
Raymond P. Warrell, Jr., M.D.
Chief Executive Officer and (Acting) Chief Financial Officer
vicl-ex101_103.htm


 

Exhibit 10.1

AMENDMENT No.1

 

This Amendment No.1 (the “Amendment”), dated as of 31st of August 2015, is by and between Vical Incorporated, a Delaware corporation (“Vical”), having an address of 10390 Pacific Center Court, San Diego, California, 92121, USA, and Astellas Pharma Inc., a company organized under the laws of Japan (“Astellas”), having an address of 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411, Japan.

 

WHEREAS, Vical and Astellas (collectively, the “Parties”) entered into a License Agreement for ASP2397, dated as of March 24, 2015 (the “Original Agreement”); and

 

WHEREAS, the Parties now desire to amend the payment terms and conditions of the Original Agreement for the first milestone event which shall be triggered by [...***...] as set forth in Section 4.2 of the Original Agreement.

 

NOW, THEREFORE, in consideration of the premises and mutual agreements set forth herein, the Parties agree to amend the Original Agreement as follows:

 

1.Definitions.  Capitalized terms used herein and not otherwise defined in this Amendment shall have the meanings ascribed to them in the Original Agreement.

 

2.New Section 1.35.The following definition shall be added to the Original Agreement as new Section 1.35, and the remaining Sections of Article 1 shall be renumbered accordingly;

 

 “1.35  “Phase I Clinical Trial” shall mean a clinical trial of a Product in humans that would provide for first testing of a Product in humans and would satisfy the requirements of 21 C.F.R. §312.21(a) or analogous regulatory requirements in the Territory.”

 

3.     Amendment to Section 4.2(i) of the Original Agreement.Vical shall pay to Astellas the first non-refundable, non-creditable milestone payment of [...***...] under Section 4.2(i) of the Original Agreement within thirty (30) days after the occurrence of either of:

 


	
 
	
(A)
	
[...***...]; or




 


	
 
	
(B)
	
[...***...];




 

Provided, however, that, if the [...***...] has occurred before [...***...] and Vical shall pay to Astellas the first milestone payment within [...***...] therefrom.

***Text Omitted and Filed Separately with the Securities and Exchange Commission. 

Confidential Treatment Requested Under 

17 C.F.R. Sections 200.80(b)(4) and 240.24b-2

 




 

 

4.     Except as set forth herein, the terms and conditions of the Original Agreement shall remain in full force and effect.  For the avoidance of doubt, the amendment to Section 4.2(i) under Clause 3 above shall not amend the other sub-sections of Section 4.2 of the Original Agreement.

 

IN WITNESS WHEREOF, the parties have executed this Amendment by their duly authorized representatives on the date first above written.

 

 

Vical Incorporated

 

 

By: /s/ VIJAY B. SAMANT

Name:  Vijay Samant

Title:  President and Chief Executive Officer

 

 

Astellas Pharma Inc.

 

 

By:/s/NAOKI OKAMURA

Name:Naoki Okamua 

Title: Vice President, Business Development

 

***Text Omitted and Filed Separately with the Securities and Exchange Commission. 

Confidential Treatment Requested Under 

17 C.F.R. Sections 200.80(b)(4) and 240.24b-2
I 

111TH CONGRESS 

2D SESSION H. R. 4547 

To designate the facility of the United States Postal Service located at 

119 Station Road in Cheyney, Pennsylvania, as the ‘‘Captain Luther 

H. Smith, U.S. Army Air Forces Post Office’’. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 27, 2010 

Mr. SESTAK (for himself, Mr. BRADY of Pennsylvania, Mr. FATTAH, Mrs. 

DAHLKEMPER, Mr. ALTMIRE, Mr. THOMPSON of Pennsylvania, Mr. GERLACH, Mr. PATRICK J. MURPHY of Pennsylvania, Mr. SHUSTER, Mr. 

CARNEY, Mr. KANJORSKI, Mr. MURTHA, Ms. SCHWARTZ, Mr. DOYLE, 

Mr. DENT, Mr. PITTS, Mr. HOLDEN, Mr. TIM MURPHY of Pennsylvania, 

and Mr. PLATTS) introduced the following bill; which was referred to the 

Committee on Oversight and Government Reform 

A BILL 

To designate the facility of the United States Postal Service 

located at 119 Station Road in Cheyney, Pennsylvania, 

as the ‘‘Captain Luther H. Smith, U.S. Army Air Forces 

Post Office’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CAPTAIN LUTHER H. SMITH, U.S. ARMY AIR 

4 FORCES POST OFFICE. 

5 (a) DESIGNATION.—The facility of the United States 

6 Postal Service located at 119 Station Road in Cheyney, 


hsrobinson on DSK69SOYB1PROD with BILLS
2 

•HR 4547 IH

1 Pennsylvania, shall be known and designated as the ‘‘Cap2 tain Luther H. Smith, U.S. Army Air Forces Post Office’’. 

3 (b) REFERENCES.—Any reference in a law, map, reg4 ulation, document, paper, or other record of the United 

5 States to the facility referred to in subsection (a) shall 

6 be deemed to be a reference to the ‘‘Captain Luther H. 

7 Smith, U.S. Army Air Forces Post Office’’. 

Æ 


hsrobinson on DSK69SOYB1PROD with BILLS
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Premiere
Technologies and is qualified in its entirety by reference to such financial
statements.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000

<S>                                        <C>                     <C>
<PERIOD-TYPE>                                3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998             DEC-31-1998
<PERIOD-START>                             JUL-01-1998             JAN-01-1998
<PERIOD-END>                               SEP-30-1998             SEP-30-1998
<CASH>                                               0                  35,314
<SECURITIES>                                         0                  30,171
<RECEIVABLES>                                        0                  61,317
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0                 188,379
<PP&E>                                               0                 133,011
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                                       0                 909,387
<CURRENT-LIABILITIES>                                0                 257,368
<BONDS>                                              0                 172,500
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                             0                     469
<OTHER-SE>                                           0                 426,686
<TOTAL-LIABILITY-AND-EQUITY>                         0                 909,387
<SALES>                                        121,540                 327,876
<TOTAL-REVENUES>                               121,540                 327,876
<CGS>                                           37,346                 101,336
<TOTAL-COSTS>                                  131,880                 377,225
<OTHER-EXPENSES>                                  (265)                    (82)
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              (4,250)                 (9,942)
<INCOME-PRETAX>                                (14,595)                (59,209)
<INCOME-TAX>                                    (2,715)                (11,177)
<INCOME-CONTINUING>                            (11,880)                (48,032)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                      (11,880)                (48,032)
<NET-INCOME>                                   (11,880)                (48,032)
<EPS-BASIC>                                      (0.26)                  (1.10)
<EPS-DILUTED>                                    (0.26)                  (1.10)


</TABLE>
UNITED STATES DISTRICT COURT 

SOUTHERN DISTRICT OF OHIO 

WESTERN DIVISION AT DAYTON 

MICHAEL E. MCGLOTHIN, 

Plaintiff, 

vs. 

COMMISSIONER OF THE SOCIAL 

SECURITY ADMINISTRATION, 

Defendant. 

:

:

:

:

:

:

:

:

:

:

Case No. 3:18-cv-52 

District Judge Thomas M. Rose 

Magistrate Judge Sharon L. Ovington 

DECISION AND ENTRY 

This case is before the Court upon Plaintiff’s Motion for an Award of Attorney 

Fees and Costs Pursuant to the Equal Access to Justice Act, (EAJA) 28 U.S.C. §2412. 

(Doc. #18). The Commissioner has neither responded to nor opposed this Motion. 

Plaintiff seeks an award of attorney fees under the EAJA in the amount of 

$6,814.08. In the absence of opposition by the Commissioner, Plaintiff’s Motion and 

supporting documents establish that he is entitled to an award of attorney fees under the 

EAJA in the total amount he seeks. The attorney fees awarded under the EAJA belong to 

Plaintiff and are subject to administrative “offset if [he] has outstanding federal debts.” 

Astrue v. Ratliff, 560 U.S. 586, 594 (2010). 

IT IS THEREFORE ORDERED THAT: 

1. Plaintiff’s Motion for an Award of Attorney Fees and Costs 

Pursuant to the Equal Access to Justice Act (Doc. #18) is 

GRANTED; 
2

2. The Commissioner shall pay Plaintiff’s attorney fees under the 

EAJA in the total amount of $6,814.08; 

3. The Commissioner shall verify, within thirty days of this 

Decision and Entry, whether or not Plaintiff owes a preexisting debt to the United States subject to offset. If no such 

pre-existing debt exists, Defendant shall pay the EAJA award 

directly to Plaintiff=s counsel; and 

4. The case remains terminated on the docket of this Court. 

IT IS SO ORDERED. 

September 10, 2019 *s/Thomas M. Rose 

 Thomas M. Rose 

 United States District Judge
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Form 10-Q of Microtune, Inc. (the Company) for the quarter ended September 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Jeffrey A. Kupp, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       |  |                                                                                       
|---------------------- |  | --------------------------------------------------------------------------------------
|                       |  | /s/ JEFFREY A. KUPP                                                                   
|                       |  | Jeffrey A. Kupp                                                                       
|                       |  | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
|                      
|Date: October 23, 2008
#### Simpson *v.*State.

4412

195 S. W. 2d 545

Opinion delivered July 1, 1946.

*O. A. Featherston,*for appellant.

*Guy E. Williams,*Attorney G-eneral, and *Earl N. Williams,*Assistant Attorney General, for appellee.»

Holt, J.

Appellant, Dr. W. B. Simpson, was found guilty by a jury on a charge of obstructing a public road and a fine of $1 assessed as punishment. This appeal followed.

The evidence is to the following effect. The road in question passes over an 80-acre tract of land .owned by *310appellant and had been used by the public for thirty-five or forty years. In 1928 or *29, appellant erected gates obstructing this road, one where the road enters his land and the other on the opposite side where it passed off his property. The gates were opened and closed by those who made use thereof. There was no statutory dedication of this road and the county court exercised no jurisdiction over it by appointing a road overseer or otherwise. No money was spent by the county in its upkeep and it was never recognized as being a part of any road district.

Some time in early November, 1945, appellant locked the two gates and denied further use of the road to the public.

In these circumstances, appellant earnestly insists that there was no substantial evidence that the road obstructed was a public road, and we think he is correct in this contention. It was necessary, of course, for the State to prove that it was a public road before a conviction could be had.

Prosecution was had under § 3434 of Pope’s Digest which provides: “If any person shall obstruct any public road by felling any tree or trees across the same, or placing any other obstruction therein, he shall be guilty of a misdemeanor, etc.”

Any prescriptive right that the public might have acquired in this road prior to 1928 or ’29 was lost by it when appellant, without objection on the part of the public, was permitted to erect the gates, *supra,*and thereafter for a period of seven years, in fact for approximately seventeen years, maintain them across this roád.

In *Porter*v. *Huff,*162 Ark. 52, 257 S. W. 393, this court said: “It is unnecessary to decide whether the public acquired a right to the use of. the road as a public road by prescription, or seven years adverse possession, for it lost any right it may have acquired by acquiescing in a permissive use thereof for a period of more than seven years after the road was closed by gates. When appellee inclosed his land and placed gates across the road, it was notice to the public that thereafter they *311were passing through the land by permission, and not by right. The undisputed- evidence shows that these gates were maintained by appellee across the road for ten or eleven years, without objection on the part of the public.” See, also, *Howard*v. *State*and *Howard*v. *State,*47 Ark. 431, 2 S. W. 331, and *Pierce*v. *Jones,*207 Ark. 139, 179 S. W. 2d 454.

Since it appears therefore that the road which appellant was charged with having obstructed was not a public road, he was guilty of no offense in obstructing it, or.in denying its further use to the public. Accordingly, the judgment is reversed and the cause dismissed.
IN THE UNITED STATES DISTRICT COURT

FOR THE SOUTHERN DISTRICT OF OHIO

EASTERN DIVISION

United States of America

v. 2:17-cr-267

Judge Marbley

Carlos Alfredo Millan-Coronel 

ORDER

There being no objections, the court hereby adopts the Report

and Recommendation of the Magistrate Judge (ECF No. 24) that the

defendant’s guilty plea be accepted. The Court accepts the

defendant’s plea of guilty to Count 1 of the Information, and he is

hereby adjudged guilty on this count. The Court will defer the

decision of whether to accept the plea agreement until the

sentencing hearing.

Date: January 11, 2018 s\Algenon L. Marbley 

 Algenon L. Marbley

 United States District Judge
EXHIBIT 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of Velocity Express Corporation (the Company) on Form 10-K for the period ended June 28, 2008, as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Vincent A. Wasik, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:



| | 1. |  | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- |  | ---------------------------------------------------------------------------------------------------------------------



| | 2. |  | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------



/s/ VINCENT A. WASIKVincent A. WasikChairman of the Board and Chief Executive OfficerOctober 14, 2008




The foregoing certification is
being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-K or as a
separate disclosure document.



A signed original of this written statement
required by Section 906 has been provided to Velocity Express Corporation and will be retained by Velocity Express Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
[Federal Register Volume 87, Number 9 (Thursday, January 13, 2022)]
[Notices]
[Page 2170]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00522]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Synthesis and Distribution of Opioid and Related 
Peptides.
    Date: January 26, 2022.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, National Institute on Drug 
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Sheila Pirooznia, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Review, 
National Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, 
MSC 6021, Bethesda, MD 20892, (301) 496-9350, 
<a href="/cdn-cgi/l/email-protection#d5a6bdb0bcb9b4fba5bca7babaafbbbcb495bbbcbdfbb2baa3"><span class="__cf_email__" data-cfemail="33405b565a5f521d435a415c5c495d5a52735d5a5b1d545c45">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse and Addiction Research Programs, National 
Institutes of Health, HHS)

    Dated: January 7, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-00522 Filed 1-12-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.2

                  Certification by the Chief Financial Officer
           Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002

      I, William P. Keane, the Chief Financial Officer of Genta Incorporated, a
Delaware corporation (the "Company"), hereby certify that:

      1.    The Company's quarterly report on Form 10-Q for the period ended
            June 30, 2003 (the "Form 10-Q") fully complies with the requirements
            of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
            amended; and

      2.    The information contained in the Form 10-Q fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.


      /s/ WILLIAM P. KEANE
      ------------------------------
      Name:  William P. Keane
      Title: Chief Financial Officer